Form D · Other Technology

BioFluidica, Inc.

San Diego, CA · CIK 0001670738

Offering snapshot reported Dec 2, 2021 · SEC filing

Reported sold
$3.54M
Offering amount: $10M
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 19, 2021
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 2, 2021Initial$3,537,700No comparison12SEC filing
Mar 29, 2021Amendment$5,981,566$2,885,000vs Dec 5, 201922SEC filing
Dec 5, 2019Initial$3,096,566No comparison18SEC filing
Nov 21, 2019Amendment$3,000,000$1,941,187vs Sep 13, 201818SEC filing
Sep 13, 2018Initial$1,058,813No comparison11SEC filing
Jul 27, 2017Initial$4,135,000No comparison9SEC filing
Jun 6, 2016Amendment$2,000,000$920,001vs Apr 18, 201610SEC filing
Apr 18, 2016Initial$1,079,999No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-423279

Source: Form D, filed Dec 2, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Philip Buchanan Director
Rolf Muller Director, Executive
Judy Muller Cohn Executive
Steven Soper Director, Executive
Michael Stocum Director
Sam C. Tetlow Director, Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
11575 Sorrento Valley Road Suite 210
San Diego, CA, 92121